Search

everythinglearnresearchcommunity

for

Search:↓

A woman's sudden hair loss three years after a bone marrow transplant was a sign of chronic graft-versus-host disease but improved with treatment.

Skin changes like hair loss, white patches, and nail changes are common in children after bone marrow transplants, often linked to chronic rejection.

The document concludes that low-dose oral minoxidil successfully regrew hair in a patient with permanent hair loss after chemotherapy and stem cell transplant.

A Japanese bone marrow transplant patient developed a rare skin cancer possibly linked to long-term use of the medication voriconazole.

Mice with human fetal thymic tissue and stem cells developed symptoms similar to chronic graft-versus-host disease.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

Newborn screening and gene therapy are expected to improve outcomes for Omenn syndrome patients.

The secretions of mesenchymal stem cells could be used for healing without using the cells themselves.

Stem cell therapies show promise for treating various diseases but face challenges in clinical use and require better monitoring techniques.

Bone-marrow and epidermal stem cells help heal wounds differently, with bone-marrow cells aiding in blood vessel formation and epidermal cells in hair growth.

Fetal-maternal stem cells in a mother's hair can help with tissue repair and regeneration long after childbirth.

In June 2019, the stem cell research field saw major progress, including new clinical trials, FDA approvals, and industry collaborations.

In September 2016, there were major advancements and promising clinical trials in stem cell research and regenerative medicine.

New treatments for hair loss show promise but need more research to confirm safety and effectiveness.

Ruxolitinib helps protect skin stem cells and keeps skin healthy in mice with skin GVHD.

Modified KGF mRNA helps skin cells grow and move faster, which may improve wound healing.

T cells and bacteria in the gut and skin help maintain health and protect against disease.

JAK inhibitors help with skin conditions but need more research on dosing and safety.

Patients with chronic graft-versus-host disease often have skin problems like vitiligo and alopecia areata.

MDSC-Exo can treat autoimmune alopecia areata and promote hair regrowth in mice.

Mast cells and CD8 T cells interact closely in skin diseases, affecting each other's behavior and contributing to conditions like psoriasis and eczema.

Long-term use of azole antifungals can cause hair loss, hormonal imbalances, and severe skin reactions.

Bioengineering can potentially treat hair loss by regenerating hair follicles and cloning hair, but the process is complex and needs more research.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Low-level laser therapy can improve hair density in people with androgenic alopecia, but more research is needed to find out who it works best for.

FGF signaling is a promising target for developing treatments for wounds, metabolic diseases, and cancer.

NEMO syndrome and systemic lupus erythematosus are linked in a new disease association.

Gray hair can potentially be reversed, leading to new treatments.

Alopecia areata patients have higher levels of certain immune receptors, suggesting new treatment possibilities.

The document lists various dermatology topics, treatments, and diagnostic methods.